Jeets traded like a swing trader over the last 30 days, with activity spread across 72 trades and 16 unique tokens. The average holding time was 327593 seconds, which points to positions being held beyond quick flips and into multi-day territory. This wallet was active, but results show broad difficulty converting that activity into realized gains. The token mix was fairly concentrated around a limited set of names rather than a very wide spray of bets, and the overall profile reads as a trader willing to re-engage with the same tokens multiple times.
Recent performance was weak across nearly every top line metric. Jeets posted -18163.67 in PnL with a -65.1% ROI during the last 30 days. Total buys reached 27900.52, while total sells came in at 8544.21, showing a large gap between capital deployed and capital recovered. The win rate was 18.75%, which means only a small share of trades finished profitably. Even with 72 total trades, the low hit rate and negative ROI suggest that trade frequency did not offset poor outcomes. This wallet’s recent record looks defined more by repeated drawdowns than by a few isolated mistakes.
The standout positive result was BXnU… at 916.05, while the worst loss came from 9rHa… at -4676.9. Looking across the top tokens, losses were widespread: 316z… lost -3046.53 in 2 trades, Efup… lost -2495.1 in 3 trades, biLu… lost -1909.94 in 3 trades, and 49jk… lost -1809.68 in 6 trades. Other notable drags included 73qW… at -1385.32, 7LiX… at -1190.31, and 5z5n… at -1056.02. Only BXnU… and CeaQ… were positive among the listed names, with CeaQ… contributing 420.82 across 15 trades.
This wallet would mainly appeal to someone specifically looking to mirror a high-activity swing trader and who is comfortable with a low recent win rate, deep drawdowns, and inconsistent token selection. Jeets does not currently look like a wallet for traders seeking steady execution or strong recent risk control. A copier would need to be comfortable following a style that holds positions for longer than intraday momentum while accepting that the latest 30-day performance has been decisively negative.